Michael Schmitt

机构：German Cancer Research Center, Heidelberg University, Leibniz Institute of Photonic Technology, University Hospital Heidelberg, National Center for Tumor Diseases, Friedrich Schiller University Jena · ORCID：0000-0002-1579-1509

发表论文 435 篇 · 总被引 12396 次 · h-index 56

代表论文

• Antibiotic-induced loss of gut microbiome metabolic output correlates with clinical responses to CAR T-cell therapy (2024 · Blood · 被引 54)
• EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma (2024 · Journal for ImmunoTherapy of Cancer · 被引 46)
• Third-generation anti-CD19 CAR T cells for relapsed/refractory chronic lymphocytic leukemia: a phase 1/2 study (2024 · Leukemia · 被引 46)
• Cardiovascular Events After Chimeric Antigen Receptor T-Cell Therapy for Advanced Hematologic Malignant Neoplasms (2024 · JAMA Network Open · 被引 30)
• CD20-bispecific antibodies improve response to CD19-CAR T cells in lymphoma in vitro and CLL in vivo models (2024 · Blood · 被引 19)
• Immunological effects of CD19.CAR-T cell therapy in systemic sclerosis: an extended case study (2024 · Arthritis Research & Therapy · 被引 18)